Wednesday, December 2, 2020

Digital Program Helped Reduce Patients’ Blood Pressure and Cholesterol Levels, Study

An algorithm-driven digital disease management program helped patients to have a significant improvement in their blood cholesterol and blood pressure levels, according to new research. The study was published Tuesday in the journal Circulation.

Technology Allows Doctors to Objectively Detect Tinnitus or Ringing Sensation in Ears

New technology can allow doctors to objectively detect tinnitus or ringing in the ears. The technology is called functional near-infrared spectroscopy (fNIRS), a non-invasive imaging procedure that measures changes in the oxygen levels within the brain. By helping detect tinnitus, fNIRS could also help doctors to assess treatment options.

Amazon Pharmacy Helps You Buy Prescriptions Medications Online With Home Delivery

Amazon is making a strong presence in the online pharmacy industry by launching Amazing Pharmacy, a digital platform where you can buy brand and generic prescription drugs online and get them delivered to your home. Amazon Prime members will get additional benefits from using the platform.

Viagra Manufacturer Pfizer and BioNTech Close To Making a Potentially Effective COVID-19 Vaccine

Viagra maker Pfizer is very close to making an effective vaccine for the prevention of COVID-19 as it announced the results of its vaccine candidate, stating that it is 90% effective in preventing COVID-19. The m-RNA-based vaccine is developed by Pfizer in associating with German-based BioNTech.

Grain German Shepherd Pills Found To Contain Undeclared Sildenafil And Paracetamol

The Australian drug regulatory body called the Therapeutic Goods Administration (TGA) has warned people against using Grain German Shepherd tablets because they were found to be tainted with undeclared sildenafil citrate (Viagra) and paracetamol (Tylenol).

Carbon Health, Buoy Health, Among Others Collect Millions of Health Funding

California-based Carbon Health has recently collected $100 million in funding to expand its healthcare service. Massachusetts-based Buoy Health received a $37.5 million fund. Other companies, such as Unlearn.AI and Togetherall, have also received funding to boost medical care services.

FDA Approves Digital Therapeutic Device for People with Nightmare Disorder

The U.S. Food and Drug Administration (FDA) has given a De Novo clearance to the Minneapolis-based company NightWare for the use of the digital therapeutic device in patients with nightmare disorder. The device helps improve the quality of sleep by preventing interruptions during sleep.